RePORT International Resources
View all training resources.
331 items found
Research Tools
NIH Extramural Nexus (News)
The NIH Extramural Nexus is the NIH's official platform for updates on grants policies, application processes, and funding news. Hosted within the NIH Grants & Funding website, it serves as a centralized resource for researchers, administrators, and institutions navigating the NIH extramural research landscape. The platform offers timely information on policy changes, application tips, and new resources, ensuring the research community stays informed and compliant with NIH requirements.
Research Tools
NIH Grants Process for Beginners: Webinar Resources Available
Learn the basics with NIH Grants Process: A Walk-Through for Beginners
Tune in for answers to your questions in the NIH Expert Q&A Panel: Part 1
Test your knowledge with Submission Policies: You Make the Call
More questions and answers in the NIH Expert Q&A Panel: Part 2
Take our panelists’ advice: Grant Application Tips from NIH Experts
Training & Conferences
NIH Office of Intramural Training and Education: Workplace Dynamics (WPD) Series
The material in this series will increase your awareness of work, communication, and conflict styles, using examples highly relevant to research environments. The series is helpful for trainees and fellows at all levels. The series is also helpful for fellows who supervise others and want to develop strong mentoring skills for the future.
There are three sessions in the series; each is offered once in the fall and spring. While it is best to attend the entire series, you may attend individual sessions. Trainees and fellows who complete all three units of the Workplace Dynamics Series will receive a certificate of completion. All three units of this series are required for participation in the OITE Management Short Course offered each spring.
Research Tools
NIH Policy & Compliance
By accepting a grant award, recipients agree to comply with the requirements in the NIH Grants Policy Statement unless the notice of award states otherwise. Please refer to the website for specific policy topic pages for additional context and resources.
Research Tools
NIH Public Access Policy Update
To advance science and improve human health, NIH makes the peer-reviewed articles it funds publicly available on PubMed Central. The 2024 NIH Public Access Policy requires Author Accepted Manuscripts accepted for publication in a journal, on or after July 1, 2025, to be submitted to PubMed Central upon acceptance for publication, for public availability without embargo upon the Official Date of Publication
Research Tools
NIH Scientific Data Sharing: Policies and Access to Data
NIH expects recipients to make the results and accomplishments of their activities available to the research community and to the public at large. These pages highlight policies and guidance on sharing and accessing research resources developed with NIH funding.
Funding
NIH Support of International Research: Navigating NIH Public Resources
Fogarty's new webpage 'NIH Support of International Research: Navigating NIH Public Resources' website page contains useful information for researchers. Alongside links to NIH Guide Notices and NIH extramural news resources, the page offers guidance on the newly published application and award structure for applications that request funding for international organizations (the PA-26-002 NIH Collaborative International Research Project--Parent PF5 Clinical Trial Optional).
Research Tools
NIH: DAIDS Learning Portal
Most important training for any investigator would be HSP/GCP where they need to learn and understand how Ethical conduct of research is done and why it is important. I have pasted various links below that cover all the topics extensively. DAIDS learning portal, HANC network , DAIDS score manual have good training modules .
Research Tools
NIH: DAIDS SCORE Manual
This document provides a detailed list of source documentation requirements during the conduct of a clinical trial. Source documentation refers to the record of the participant before, during and after a trial.
Funding
NIH: Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Application due date: Multiple dates, see announcement
Funding
NIH: Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Application due date: Multiple dates, see announcement
Funding
NIH: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant.
All applications must be within the scope of the mission of one of the Institutes/Centers listed in the notice.
Application DEADLINE: Multiple dates, see announcement.
Funding
NIH: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Application due date: Multiple dates, see announcement
Research Tools
NIH: Peer Review Webinars & Videos
The NIH Center for Scientific Review has produced a series of webinars and videos to give you an inside look at how scientists from across the country review NIH grant applications for scientific and technical merit.
Training & Conferences
NIH: Pragmatic and Group-Randomized Trials in Public Health and Medicine
This online course is presented by Dr. David M. Murray, the NIH Associate Director for Prevention and Director of Office of Disease Prevention. This course, updated in September 2024, is meant to help researchers design trials involving groups or clusters.
Research Tools
NLM Style Guide for Authors, Editors, and Publishers
Citing Medicine provides assistance to authors in compiling lists of references for their publications, to editors in revising such lists, to publishers in setting reference standards for their authors and editors, and to librarians and others in formatting bibliographic citations.
Funding
NOFO: Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)
Open Date (Earliest Submission Date): April 07, 2025; Expiration Date: January 08, 2028
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is five years.
Funding
NOFO: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
Open Date (Earliest Submission Date): May 07, 2025; Expiration Date: January 08, 2028
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is five years.
Funding
NOFO: Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
Open Date (Earliest Submission Date): May 07, 2025; Expiration Date: January 08, 2028
Award Budget: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 in direct costs may be requested in any single year.
Award Project Period may not exceed 2 years.
Funding
Notice of Special Interest (NOSI): Investigating TB Pathogenesis and Host Immunity to Preserve Lung Health After TB
Contact: Robert Mahon Robert.Mahon@nih.gov
Objective: The scientific objectives of this new initiative are to 1) better understand the types and pathogenesis of long-term lung damage resulting from pulmonary tuberculosis (TB) and the role of the host immune response, and 2) identify ways to mitigate lung damage during TB treatment through host-directed therapy. There is no set-aside funding for this NOSI.